Immunogenicity of variable regions of hepatitis C virus proteins: Selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA

Journal of General Virology

Volumn 80, Issue 3, 1999, Pages 727-738

  Rodríguez López, Marta ^a   Riezu Boj, José Ignacio ^a   Ruiz, Marta ^a   Berasain, Carmen ^a   Civeira, Maria Pilar ^a   Prieto, Jesús ^a   Borrás Cuesta, Francisco ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; VIRUS PROTEIN;

ARTICLE; B LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; MAJOR CLINICAL STUDY; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0344937991     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-3-727     Document Type: Article

References (61)

1. Agence du Médicaments, France (1996). Drug agency evaluation of RIBA serotyping versus Murex HCV serotyping 1-3. Report on Murex Assay.
2. Alter, H. J. (1989). Chronic consequences of non-A, non-B hepatitis. In Current Prospective in Hepatology, pp. 83-37. New York: Plenum.
3. Atherton, E., Logan, J. & Sheppard, C. (1981). Peptide synthesis. Part 2. Procedures for solid phase synthesis using N-fluorenil metoxycarbonil amino acids on polyamide supports. Synthesis of substance P and of acyl carrier protein 65-74 decapeptide. Journal of the Chemical Society Perkin Transactions 1, 538-546.
4. Bell, H., Helium, K., Harthug, S., Maeland, A., Ritland, S., Myrvang, B., von der Lippe, B., Raknerud, N., Skaug, K., Gutigard, B. G., Skjaerven, R., Prescott, L. E. & Simmonds, P. (1997). Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct Group. Scandinavian Journal of Infectious Diseases 29, 17-22.
5. Berasain, C., García-Granero, M., Riezu-Boj, J. I., Prieto, J. & Borrás-Cuesta, F. (1993). Detection of anti-hepatitis C virus antibodies by ELISA using synthetic peptides. Journal of Hepatology 18, 80-84.
6. Borrás-Cuesta, F., Fedon, Y. & Petit-Camurdan, A. (1988). Enhancement of peptide immunogenicity by linear polymerization. European Journal of Immunology 18, 199-202.
7. Borrás-Cuesta, F., Golvano, J., Sarobe, P., Lasarte, J. J., Prieto, I., Szabo, A., Guillaume, J. L. & Guillet, J.-G. (1991). Insights on the amino acid side-chain interactions of a synthetic T-cell determinant. Biologicals 19, 187-190.
8. Brechot, C. (1996). Hepatitis C virus: molecular biology and genetic variability. Digestive Diseases and Sciences 41 (Suppl. 12), 6S-21S.
9. Bukh, J., Purcell, R. H. & Miller, R. H. (1993). At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proceedings of the National Academy of Sciences, USA 90, 8234-8238.
10. Cerino, A., Cividini, A., Asti, M., Lanza, A., Silini, E. & Mondelli, M. (1996). Comparative evaluation of two serologic typing methods for hepatitis C virus. Journal of Clinical Microbiology 34, 714-716.
11. Choo, Q. L., Weiner, A. J., Overby, L. R., Bradley, D. W. & Houghton, M. (1989). Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome. Science 244, 359-362.
12. Choo, Q. L., Richman, K. H., Han, J. H., Berger, K., Lee, C., Dong, C., Gallegos, C., Coit, D., Medina-Selby, R., Barr, P. J., Weiner, A. J., Bradley, D. W., Kuo, G. & Houghton, M. (1991). Genetic organization and diversity of the hepatitis C virus. Proceedings of the National Academy of Sciences, USA 88, 2451-2455.
13. Darwish, M. A., Raouf, T. A., Rushdy, P., Constantine, N. T., Rao, M. R. & Edelman, R. ( 1993). Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. American Journal of Tropical Medicine and Hygiene 49, 440-447.
14. Davidson, F., Simmonds, P., Ferguson, J. C., Jarvis, L. M., Dow, B. C., Follett, E. A. C., Seed, C. R. G., Krusius, T., Lin, C., Medgyesi, G. A., Kiyokawa, H., Olim, G., Duraisamy, G., Cuypers, T., Saeed, A. A., Teo, D., Conradie, J., Kew, M. C., Lin, M., Nuchaprayoon, C., Ndimbie, O. K. & Yap, P. L. (1995). Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. Journal of General Virology 76, 1197-1204.
15. Davis, G. L. & Lau, J. Y. N. (1997). Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology 26 (Suppl. 1), 122S-127S.
16. Dhaliwal, S. K., Prescott, L. E., Dow, B. C., Davidson, F., Brown, H., Yap, P. L., Follett, E. A. & Simmonds, P. (1996). Influence of viraemia and genotype upon serological reactivity in screening assays for antibody to hepatitis C virus. Journal of Medical Virology 48, 184-190.
17. Dusheiko, G., Schmilovitz-Weiss, H., Brown, D., McOmish, F., Yap, P. L., Sherlock, S., McIntyre, N. & Simmonds, P. (1994). Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 19, 13-18.
18. Forns, X., Maluenda, M. D., López-Labrador, F. X., Ampurdanés, S., Olmedo, E., Costa, J., Simmonds, P., Sanchez-Tapias, J. M., Jimenez De Anta, M. T. & Rodes, J. (1996). Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients. Journal of Clinical Microbiology 34, 2516-2521.
19. Garson, J. A., Ring, C., Tuke, P. & Tedder, R. S. (1990). Enhanced detection by PCR of hepatitis C virus RNA. Lancet ii, 878-879.
20. Gavier, B., Martinez-González, M. A., Riezu-Boj, J. I., Lasarte, J. J., Garcia, N., Civeira, M. P. & Prieto, J. (1997). Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C. Gastroenterology 113, 1647-1653.
21. Gournay, J., Marcellin, P., Martinot-Peignoux, M., Degott, C., Gabriel, F., Courtois, F., Branger, M., Wild, A. M., Erlinger, S. & Benhamou, J. P. (1995). Hepatitis C virus genotypes in French blood donors. Journal of Medical Virology 45, 399-404.
22. Hino, K., Sainokami, S., Shimoda, K., Iino, S., Wang, Y., Okamoto, H., Miyakawa, Y. & Mayumi, M. (1994). Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. Journal of Medical Virology 42, 299-305.
23. Hopf, V., Berg, T., König, V., Küther, S., Heuft, H. G. & Lobeck, H. (1996). Treatment of chronic hepatitis C with interferon alpha: longterm follow up and prognosis relevance of HCV genotypes. Journal of Hepatology 24 (Suppl. 2), 67-73.
24. Kato, N., Hijikata, M., Ootsuyama, Y., Nakagawa, M., Ohkoshi, S., Sugimura, T. & Shimotohno, K. (1990). Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proceedings of the National Academy of Sciences, USA 87, 9524-9528.
25. Ko, Y. C., Ho, M. S., Chiang, T. A., Chang, S. J. & Chang, P. Y. (1992). Tattooing as a risk of hepatitis C virus infection. Journal of Medical Virology 38, 288-291.
26. Kuo, G., Choo, Q., Alter, H., Gitnick, G., Redeker, A., Purcell, R., Miyamura, T., Dienstag, J, L., Alter, M. J., Stevens, C. E., Tegtmeier, G., Bonino, F., Colombo, M., Lee, W., Kuo, C., Berger, K., Shuster, J., Overby, L., Bradley, D. & Houghton, M. (1989). An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244, 362-364.
27. Larrea, E., García, N., Qian, C., Civeira, M. P. & Prieto, J. (1996). Tumor necrosis factor α gene expression and the response to interferon in chronic hepatitis C. Hepatology 23, 210-217.
28. Lau, J. Y. N., Mizokami, M., Ohno, T., Diamond, D. A., Kniffen, J. & Davis, G. L. (1993). Discrepancy between biochemical and virological responses to interferon-α in chronic hepatitis C. Lancet 342, 1208-1209.
29. Lohr, H. F., Elste, C., Dienes, H. P., Michel, G., Braun, H. B., Meyer zum Buschenfelde, K. H. & Gerken, G. (1996). The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha. Journal of Hepatology 25, 292-300.
30. Machida, A., Ohnuma, H., Tsuda, F., Munekata, E., Tanaka, T., Akahane, Y., Okamoto, H. & Mishiro, S. (1992). Two distinct subtypes of hepatitis C virus defined by antibodies directed to putative core protein. Hepatology 16, 886-891.
31. Martinot-Peignoux, M., Marcellin, P., Pouteau, M., Castelnau, C., Boyer, N., Poliquin, M., Degott, C., Descombes, I., Le Breton, V., Milotova, V., Benhamou, J. P. & Erlinger, S. (1995). Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon-alpha therapy in chronic hepatitis C. Hepatology 22, 1050-1056.
32. Mellor, J., Holmes, E. C., Jarvis, L. M., Yap, P. L., Simmonds, P. & The International HCV Collaborative Study Group (1995). Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. Journal of General Virology 76, 2493-2507.
33. Merrifield, R. (1963). Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. Journal of the American Chemical Society 85, 2149-2154.
34. Okamoto, H., Sugiyama, Y., Okada, S., Kurai, K., Akahane, Y., Sugai, Y., Tanaka, T., Sato, K., Tsuda, F., Miyakawa, Y. & Mayumi, M. (1992). Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. Journal of General Virology 73, 673-679.
35. Pawlotsky, J. M., Prescott, L., Simmonds, P., Pellet, C., Laurent-Puig, P., Labonne, C., Darthuy, F., Remire, J., Duval, J., Buffet, C., Etienne, J. P., Dhumeaux, D. & Dussaix, E. (1997). Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay. Journal of Clinical Microbiology 35, 1734-1739.
36. Pereira, B. J., Milford, E. L., Kirkman, R. L. & Levey, A. S. (1991). Transmission of hepatitis C virus by organ transplantation. New England Journal of Medicine 325, 454-460.
37. Polish, L. B., Tong, M. J., Co, R. L., Coleman, P. J. & Alter, M. J. (1993). Risk factors for hepatitis C virus infection among health care personnel in a community hospital. American Journal of Infection Control 21, 196-200.
38. Pozzato, G., Kaneko, S., Moretti, M., Saveria, L., Franzin, F., Unoura, M., Bercich, L., Tiribelli, C., Crovatto, M., Santini, G. & Kobayashi, K. (1994). Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. Journal of Medical Virology 43, 291-296.
39. Rall, C. J. & Dienstag, J. L. (1995). Epidemiology of hepatitis C virus infection. Seminars in Gastrointestinal Disease 6, 3-12.
40. Sakugawa, H., Nakasone, H., Kinjo, F., Saito, A., Keida, Y., Kikuchi, K., Oyadomari, Y., Ishihara, M., Nakasone, K., Yogi, S., Kinjo, Y. & Taira, M. (1997). Clinical features of patients with chronic liver disease associated with hepatitis C virus genotype 1a/I in Okinawa, Japan. Journal of Gastroenterology and Hepatology 12, 176-181.
41. Sarobe, P., Lasarte, J. J., Golvano, J. J., Prieto, I., Gullón, A., Soto, M. J., Labarga, P., Prieto, J. & Borrás-Cuesta, F. (1994). Induction of neutralizing antibodies against human immunodeficiency virus type 1 using synthetic peptide constructs containing an immunodominant T-helper cell determinant from vpr. Journal of Acquired Immune Deficiency Syndromes 7, 635-640.
42. Shakil, A. O., Conry-Cantilena, C., Alter, H. J., Hayashi, P., Kleiner, D. E., Tedeschi, V., Krawczynski, K., Conjeevaram, H. S., Sallie, R. & Di Bisceglie, A. M. (1995). Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group. Annals of Internal Medicine 123, 330-337.
43. Simmonds, P. (1995). Variability of hepatitis C virus. Hepatology 21, 570-583.
44. Simmonds, P., Rose, K. A., Graham, S., Chan, S. W., McOmish, F., Dow, B.C., Follett, E. A., Yap, P. L. & Marsden, H. (1993). Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. Journal of Clinical Microbiology 31, 1493-1503.
45. Simmonds, P., Alberti, A., Alter, H. J., Bonino, F., Bradley, D. W., Brechot, D., Brouwer, J. T., Chan, S. W., Chayama, K., Chen, D. S., Choo, Q.-L., Colombo, M., Cuypers, H. T. M., Date, T., Dusheiko, G. M., Esteban, J. I., Fay, O., Hadziyannis, S. J., Han, J., Hatzakis, A., Holmes, E. C., Hotta, H., Houghton, M., Irvine, B., Kohara, M., Kolberg, J. A., Kuo, G., Lau, J. Y. N., Lelie, P. N., Maertens, G., McOmish, F., Miyamura, T., Mizokami, M., Nomoto, A., Prince, A. M., Reesink, H. W., Rice, C., Roggendorf, M., Schalm, S., Shikata, T., Shimotohno, K., Stuyver, L., Trépo, C., Weiner, A., Yap, P. L. & Urdea, M. S. (1994). A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19, 1321-1334.
46. Smith, D. B., Pathirana, S., Davidson, F., Lawlor, E., Power, J., Yap, P. L. & Simmonds, P. (1997). The origin of hepatitis C virus genotypes. Journal of General Virology 78, 321-328.
47. Takada, A., Tsutsumi, M., Zhang, S. C., Okanoue, T., Matsushima, T., Fujiyama, S. & Komatsu, M. (1996). Relationship between hepatocellular carcinoma and subtypes of hepatitis C virus: a nationwide analysis. Journal of Gastroenterology and Hepatology 11, 166-169.
48. Takamizawa, A., Mori, C., Fuke, Y., Manabe, S., Murakami, S., Fujita, J., Onishi, E., Andoh, T., Yoshida, I. & Okayama, H. (1991). Structure and organization of the hepatitis C virus genome isolated from human carriers. Journal of Virology 65, 1105-1113.
49. Tanaka, T., Tsukiyama-Kohara, K., Yamaguchi, K., Yagi, S., Tanaka, S., Hasegawa, A., Ohta, Y., Hattori, N. & Kohara, M. (1994). Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology 19, 1347-1353.
50. Tsubota, A., Chayama, K., Ikeda, K., Yasuji, A., Koida, I., Saitoh, S., Hashimoto, M., Iwasaki, S., Kobayashi, M. & Hiromitsu, K. (1994). Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 19, 1088-1094.
51. Tsukiyama-Kohara, K., Kohara, M., Yamaguchi, K., Maki, N., Toyoshima, A., Miki, K., Tanaka, S., Hattori, N. & Nomoto, A. (1991). A second group of hepatitis C viruses. Virus Genes 5, 243-254.
52. Tsukiyama-Kohara, K., Yamaguchi, K., Maki, N., Ohta, Y., Miki, K., Mizokami, M., Ohba, K., Tanaka, S., Hattoti, N., Nomoto, A. & Kohara, M. (1993). Antigenicities of group 1 and II hepatitis C virus polypeptides - molecular basis of diagnosis. Virology 192, 430-437.
53. Tsukuma, H., Hiyama, T., Tanaka, S., Nakao, M., Yabuuchi, T., Kitamura, T., Nakanishi, K., Fujimoto, I., Inoue, A., Yamazaki, H. & Kawashima, T. (1993). Risk factors for hepatocellular carcinoma among patients with chronic liver disease. New England Journal of Medicine 328, 1797-1801.
54. van Doorn, L. J., Kleter, B., Pike, I. & Quint, W. (1996). Analysis of hepatitis C virus isolates by serotyping and genotyping. Journal of Clinical Microbiology 34, 1784-1787.
55. Viazov, S., Zibert, A., Ramakrishnan, K., Widell, A., Cavicchini, A., Schreier, E. & Roggendorf, M. (1994). Typing of hepatitis C virus isolates by DNA enzyme immunoassay. Journal of Virological Methods 48, 81-91.
56. Vrielink, H., Zaaijer, H. L., Reesink, H. W., Lelie, P. N. & van der Poel, C. L. (1995). Comparison of two anti-hepatitis C virus enzyme-linked immunosorbent assays. Transfusion 35, 601-604.
57. Yamada, G., Takahashi, M., Miyamoto, R., Tsuji, T., Yoshizawa, H. & Okamoto, H. (1994). Prediction of interferon effect in chronic hepatitis C by both quantification and genotyping of HCV-RNA. Digestive Diseases and Sciences 39, 441.
58. Yoshioka, K., Kakumu, S., Wakita, T., Ishikawa, T., Itoh, Y., Takayanagi, M., Higashi, Y., Shibata, M. & Morishima, T. (1992). Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 16, 293-299.
59. Zein, N. N., Rakela, J., Poterucha, J. J., Steers, J. L., Wiesner, R. H. & Persing, D. H. (1995 a). Hepatitis C genotypes in liver transplant recipients: distribution and 1-year follow-up. Liver Transplantation and Surgery 1, 354-357.
60. Zein, N. N., Poterucha, J. J., Wiesner, R. H., Gross, J. B., Gossard, A. A., Wendt, N. K., Mitchell, P. S., Germer, J. J. & Persing, D. H. (1995 b). Hepatocellular carcinoma in patients infected with different hepatitis C genotypes. Gastroenterology 108 (Suppl. 1), A1207.
61. Zein, N. N., Rakela, J., Krawitt, E. L., Reddy, K. R., Tominaga, T. & Persing, D. H. (1996). Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Annals of Internal Medicine 125, 634-639.